//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दी
| 21 October, 2020, 07:00 AM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Dr. Reddy's Laboratories Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 20 Oct, 2020, 03:59 PM IST
    5071.15

    Today's Change

    13.00 (0.26%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    1,380,290

    Open

    5056.95

    Prev. Close

    5058.15

    Day's Trend

    Low
    5030.95
    High
    5110.00
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)5.00
    • EPS-TTM (Rs.)116.92
    • BV/share (₹)938.16
    • 52Wk L/H2495.05/ 5512.65
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News

    Dr. Reddy's Laboratories Ltd Stock Price F & O Quotes

    Buy Dr Reddy's Labs, target price Rs 4,426: Nomura| Recos
    Buy
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Shareholding for the Period Ended September 30, 2020| Announcement
    Dr. Reddy's Laboratories Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Dr. Reddy's Laboratories Ltd.Compliance Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Dis...| Announcement
    Dr. Reddy's Laboratories Ltd.Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations An...| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended September 2020| Announcement
    Dr. Reddy's Laboratories Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Dr. Reddy's Laboratories Ltd.Closure of Trading Window| Announcement
    Dr. Reddy's Laboratories Ltd.Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And ...| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Dr. Reddy's Laboratories Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS| Announcement

    Dr. Reddy's Laboratories Ltd. Share Price Updates

    Dr. Reddy's Laboratories Ltd. share price up by 0.26% from its previous close of Rs 5058.15. Dr. Reddy's Laboratories Ltd. stock last traded price is 5071.15
    Dr. Reddy's Laboratories Ltd. Share Price
    Value
    Today/Current/Last
    5071.15
    Previous Day
    5058.15
    What's your view on Dr. Reddy's Laboratories for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Dr. Reddy's Laboratories Ltd.

    Dr. Reddy's Laboratories Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    4,417.50
    -0.32
    14.93
    0.00
    7585.25
    Other Operating Income
    9.00
    -47.37
    -38.36
    -0.72
    118.06
    Operating Profit
    1,121.30
    18.13
    51.18
    -14.20
    2526.83
    Other Income
    87.10
    18.34
    -79.75
    0.00
    153.79
    EBITDA
    1,208.40
    18.15
    3.12
    -14.20
    2526.83
    Interest
    23.30
    1.30
    -21.81
    0.00
    102.00
    Depreciation
    292.30
    6.64
    1.14
    0.00
    495.92
    Tax
    305.90
    NA
    58.66
    -110.66
    305.90
    Net Profit
    594.60
    -23.88
    -12.11
    -1655.60
    780.58
    EPS (₹)
    35.78
    -23.92
    -12.17
    -10.81
    68.30

    Dr. Reddy's Laboratories Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    5071.15
    0.26
    -1.89
    -4.92
    23.93
    86.11
    113.70
    17.40
    1008.70
    -0.54
    -4.41
    -7.11
    16.71
    36.48
    -4.04
    -51.40
    486.35
    0.56
    -3.34
    -7.07
    0.53
    21.09
    -9.22
    -46.11
    800.30
    -0.04
    -1.20
    -3.36
    -2.83
    67.97
    6.13
    -1.59
    428.20
    1.30
    -0.44
    4.52
    14.40
    77.93
    -12.75
    -0.91
    2665.70
    0.54
    -0.73
    -7.28
    6.32
    36.08
    45.65
    0.00
    764.30
    0.04
    -2.90
    -5.20
    13.34
    72.08
    25.75
    13.46
    2711.65
    1.44
    -3.63
    -5.72
    14.30
    60.96
    99.03
    77.02
    2074.50
    -1.00
    -2.36
    -4.28
    15.91
    119.13
    318.50
    175.72
    3085.75
    -0.25
    -1.70
    -7.73
    34.24
    77.55
    250.71
    186.00
    439.80
    0.43
    -2.59
    -3.13
    2.76
    69.51
    133.77
    477.01
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Dr. Reddy's Laboratories Ltd Risk Return Comparison

    with peersNew

    Dr. Reddy's Laboratories Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Dr. Reddy's Laboratories Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    12.98
    6.13
    -97.73
    37.52
    Return on Assets (%)
    9.86
    4.29
    -51.80
    37.98
    Return on capital Employed (%)
    6.31
    7.15
    -86.49
    32.77
    Fixed Assets Turnover (x)
    1.01
    0.43
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    7.46
    -3.48
    -831.69
    43.32
    Operating Profit Margin(%)
    14.10
    3.00
    -802.77
    46.18
    Net Profit margin (%)
    11.56
    -9.08
    -653.62
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.27
    2.00
    0.08
    37.52
    Current Ratio (x)
    2.08
    2.77
    0.21
    37.52
    Cash ratio (x)
    0.04
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.01
    0.24
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    0.57
    2.78
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Dr. Reddy's Laboratories Ltd Share Holding as on 30-09-2020

    CategoryNo. of sharesPercentage
    Promoters44,458,52826.74
    ForeignInstitutions49,176,66829.58
    NBanksMutualFunds18,906,25411.37
    Others36,669,01222.05
    GeneralPublic12,430,2247.48
    FinancialInstitutions4,245,5392.55
    GDR383,0540.23

    MF Ownership Of Dr. Reddy's Laboratories Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    SBI ETF Nifty 50-D
    Portfolio as on 30-09-2020
    Equity: Large Cap
    1873634
    -1.30%
    1.3%
    972.00
    Axis Long Term Equity Direct-G
    Portfolio as on 30-09-2020
    Equity: ELSS
    1340595
    26.71%
    3.19%
    695.47
    Aditya Birla SL Equity Direct-G
    Portfolio as on 30-09-2020
    Equity: Multi Cap
    1309911
    0.00%
    6.27%
    679.56
    SBI Equity Hybrid Direct-G
    Portfolio as on 30-09-2020
    Hybrid: Aggressive Hybrid
    1144830
    0.00%
    1.9%
    593.91
    Axis Bluechip Direct-G
    Portfolio as on 30-09-2020
    Equity: Large Cap
    1070000
    20.63%
    3.21%
    555.09

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Dr. Reddy's Laboratories Ltd.

    Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 84317.65 Crore) operating in Pharmaceuticals sector.

    Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10992.50 Crore to Sales Value (92.76 % of Total Sales), Licence Fees which contributed Rs 768.90 Crore to Sales Value (6.48 % of Total Sales), Service Income which contributed Rs 41.60 Crore to Sales Value (0.35 % of Total Sales), Spent Chemicals which contributed Rs 30.60 Crore to Sales Value (0.25 % of Total Sales), Scrap which contributed Rs 13.70 Crore to Sales Value (0.11 % of Total Sales) and Other Operating Revenue which contributed Rs 3.10 Crore to Sales Value (0.02 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 4417.50 Crore, down -.32 % from last quarter Sales of Rs 4431.80 Crore and up 14.93 % from last year same quarter Sales of Rs 3843.60 Crore Company has reported net profit after tax of Rs 586.90 Crore in latest quarter.

    The company’s top management includes Dr.Bruce L A Carter, Ms.Kalpana Morparia, Mr.Sridar Iyengar, Mr.Prasad R Menon, Mr.Leo Puri, Mr.K Satish Reddy, Mr.G V Prasad, Mr.Bharat N Doshi, Mr.Allan Oberman, Ms.Shikha Sharma. Company has S R Batliboi & Associates LLP as its auditors. As on 30-09-2020, the company has a total of 166,269,279 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors